Loading clinical trials...
Loading clinical trials...
The purpose of this study is to learn how to provide BRCA gene testing to a larger number of people as well as to make testing part of a person's regular medical care.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
NCT06201234 · Hormone Receptor Positive HER-2 Negative Breast Cancer, Advanced or Metastatic Breast Cancer, and more
NCT04613440 · BRCA1 Mutation, BRCA2 Mutation
NCT04095195 · Familial Pancreatic Cancer, BRCA1 Mutation, and more
NCT04273542 · Breast Cancer Female, BRCA1 Mutation, and more
NCT01905046 · Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, and more
University of California, Los Angeles
Los Angeles, California
Dana Farber Cancer Institute
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions